Actress Pamela Anderson, who has battled Hepatitis C for 16 years, says that her doctors have prescribed a new Food and Drug Administration approved drug regimen that eradicates the virus and this has given her new hope.
"I'm very fortunate that I've had Hep C for about 16 years. Sixteen years ago that was (presented to me) as a death sentence. I think it really worked on my self-esteem. Even though I may have looked confident on the outside, I think it really was a dark cloud that lingered over me," Anderson told people.com.
After experimenting with various alternative medicines, the "Baywatch" star decided to try the new anti-viral medication.
She said: "I could be Hep C free within the month. I don't have any liver damage and I don't have any side effects.
"I'm living my life the way I want to but it could have eventually have caused me some problems and so it was a real blessing that I was able to get the medicine. I'm half way there."
Anderson, who's the author of the new coffee table book "Raw", is really excited about it.
"I feel good. I feel so blessed. I've always been an advocate of trying to remove stigma from hepatitis C from aids. I think subconsciously (the disease) just works on you," she said.
The 48-year-old also feels better than ever.
"I actually just look in the mirror everyday and I feel like I'm looking younger and younger and I feel like I'm getting those 20 years back," she said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
